Papers
3
Total Citations
156
H-Index
3
About
Dr. Carlo Sposito is a leading figure in surgical oncology, whose research is reshaping the landscape of minimally invasive liver surgery. His work primarily focuses on the comparative efficacy and oncologic outcomes of robotic, laparoscopic, and open liver resections for hepatocellular carcinoma (HCC). Dr. Sposito’s most impactful contribution is a landmark 2022 study, cited 138 times, which provided critical long-term data on the safety and efficacy of robotic versus open liver resection for HCC—a hotly debated topic in surgical oncology. This work, alongside a 2025 multicentric analysis of 647 patients, has established him as a key voice in the field. He is also a driving force behind the Italian "I Go MILS" registry, a vital tool for disseminating best practices and fostering collaboration in minimally invasive surgery. With a career dedicated to generating high-quality evidence, Dr. Sposito’s research directly informs clinical decision-making, helping surgeons and patients navigate the complex trade-offs between surgical approaches to achieve the best possible outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3